Why Moderna Stock Plunged Today

Shares of Moderna (NASDAQ: MRNA) fell 9% on Tuesday as the biotech raced to determine if its coronavirus vaccine is effective against a highly contagious new strain of the virus. So what. Investors and the world at large cheered when a phase 3 clinical trial ...

from Google Alert - Business https://ift.tt/37GC66B
Shares of Moderna (NASDAQ: MRNA) fell 9% on Tuesday as the biotech raced to determine if its coronavirus vaccine is effective against a highly contagious new strain of the virus. So what. Investors and the world at large cheered when a phase 3 clinical trial ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize